Patent · US Active

Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylurea

US11896585B2 · kind B2 · utility

0Cited by

95References

5Claims

0Family size

Assignee

Deciphera Pharmaceuticals, LLC · US

Inventors

Michael D. Kaufman · Waltham, US
Scott Bone · Bend, US
Corey Bloom · Bend, US
Fred Jordan · Bend, US

Key dates

Filing date	Dec 30, 2022
Grant date	Feb 13, 2024
Priority date	—
Expiry date	Apr 2, 2043

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D471/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are low impurity compositions comprising a compound represented by Formula (I): which are useful in the treatment of disorders related to the activity of the c-KIT and PDGFRα kinases, and oncogenic forms thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.